WallStreetZenWallStreetZen

Stock ScreenerStock IdeasHigh Risk, High Reward
High Risk, High Reward Stocks
Speculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!

Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
Ticker
Company
Dividends Score
Market Cap
Dividend Yield
Payout Ratio
Last Dividend
Annual Dividend
Dividend Percentile
Dividend Dropped Count (L10Y)
Ex-dividend Date
Div. Payment Date
GLYC
GLYCOMIMETICS INC
$17.21MN/A0.00%N/AN/AN/AN/A
INTZ
INTRUSION INC
$3.13MN/A0.00%N/AN/AN/AN/A
ASLN
ASLAN PHARMACEUTICALS LTD
$7.67MN/A0.00%N/AN/AN/AN/A
PPBT
PURPLE BIOTECH LTD
$10.42MN/AN/AN/AN/AN/AN/A
IQ
IQIYI INC
$4.70BN/A0.00%N/AN/AN/AN/A
GOEV
CANOO INC
$164.86MN/A0.00%N/AN/AN/AN/A
CLNN
CLENE INC
$49.70MN/A0.00%N/AN/AN/AN/A
LIFE
ATYR PHARMA INC
$116.63MN/A0.00%N/AN/AN/AN/A
BPTH
BIO-PATH HOLDINGS INC
$1.85MN/A0.00%N/AN/AN/AN/A
KZR
KEZAR LIFE SCIENCES INC
$56.28MN/A0.00%N/AN/AN/AN/A
CLDI
CALIDI BIOTHERAPEUTICS INC
$8.39MN/A0.00%N/AN/AN/AN/A
BIOL
BIOLASE INC
$5.50MN/A0.00%N/AN/AN/AN/A
CKPT
CHECKPOINT THERAPEUTICS INC
$55.28MN/A0.00%N/AN/AN/AN/A
LYRA
LYRA THERAPEUTICS INC
$22.68MN/A0.00%N/AN/AN/AN/A
OCUP
OCUPHIRE PHARMA INC
$44.59MN/A0.00%N/AN/AN/AN/A
GOSS
GOSSAMER BIO INC
$167.85MN/A0.00%N/AN/AN/AN/A
AADI
AADI BIOSCIENCE INC
$43.71MN/A0.00%N/AN/AN/AN/A
APLM
APOLLOMICS INC
$33.29MN/A0.00%N/AN/AN/AN/A
APTO
APTOSE BIOSCIENCES INC
$19.33MN/A0.00%N/AN/AN/AN/A
VIRX
VIRACTA THERAPEUTICS INC
$29.85MN/A0.00%N/AN/AN/AN/A
SONN
SONNET BIOTHERAPEUTICS HOLDINGS INC
$5.22MN/A0.00%N/AN/AN/AN/A
MVST
MICROVAST HOLDINGS INC
$135.13MN/A0.00%N/AN/AN/AN/A
RVPH
REVIVA PHARMACEUTICALS HOLDINGS INC
$52.21MN/A0.00%N/AN/AN/AN/A
FEMY
FEMASYS INC
$26.89MN/A0.00%N/AN/AN/AN/A
IMRX
IMMUNEERING CORP
$43.00MN/A0.00%N/AN/AN/AN/A
BNED
BARNES & NOBLE EDUCATION INC
$15.47MN/A0.00%N/AN/AN/AN/A
YTEN
YIELD10 BIOSCIENCE INC
$3.88MN/A0.00%N/AN/AN/AN/A
TARA
PROTARA THERAPEUTICS INC
$61.77MN/A0.00%N/AN/AN/AN/A
MIST
MILESTONE PHARMACEUTICALS INC
$90.35MN/A0.00%N/AN/AN/AN/A
INAB
IN8BIO INC
$44.57MN/A0.00%N/AN/AN/AN/A
SYBX
SYNLOGIC INC
$20.85MN/A0.00%N/AN/AN/AN/A
GNLX
GENELUX CORP
$103.40MN/A0.00%N/AN/AN/AN/A
GEVO
GEVO INC
$169.14MN/A0.00%N/AN/AN/AN/A
VOR
VOR BIOPHARMA INC
$116.72MN/A0.00%N/AN/AN/AN/A
MRNS
MARINUS PHARMACEUTICALS INC
$73.06MN/A0.00%N/AN/AN/AN/A
PRST
PRESTO AUTOMATION INC
$13.41MN/A0.00%N/AN/AN/AN/A
PGEN
PRECIGEN INC
$316.13MN/A0.00%N/AN/AN/AN/A
EOSE
EOS ENERGY ENTERPRISES INC
$146.92MN/A0.00%N/AN/AN/AN/A
CMMB
CHEMOMAB THERAPEUTICS LTD
$11.93MN/A0.00%N/AN/AN/AN/A
ACET
ADICET BIO INC
$120.77MN/A0.00%N/AN/AN/AN/A
TPST
TEMPEST THERAPEUTICS INC
$72.21MN/A0.00%N/AN/AN/AN/A
GRTS
GRITSTONE BIO INC
$85.12MN/A0.00%N/AN/AN/AN/A
CVKD
CADRENAL THERAPEUTICS INC
$7.36MN/A0.00%N/AN/AN/AN/A
LUMO
LUMOS PHARMA INC
$23.51MN/A0.00%N/AN/AN/AN/A
FBIO
FORTRESS BIOTECH INC
$32.12MN/A0.00%N/AN/AN/AN/A
SGMT
SAGIMET BIOSCIENCES INC
$141.70MN/A0.00%N/AN/AN/AN/A
IKNA
IKENA ONCOLOGY INC
$62.25MN/A0.00%N/AN/AN/AN/A
MBRX
MOLECULIN BIOTECH INC
$11.00MN/A0.00%N/AN/AN/AN/A
OTLK
OUTLOOK THERAPEUTICS INC
$98.64MN/A0.00%N/AN/AN/AN/A
CMPS
COMPASS PATHWAYS PLC
$537.47MN/A0.00%N/AN/AN/AN/A
AGEN
AGENUS INC
$220.28MN/A0.00%N/AN/AN/AN/A
AQMS
AQUA METALS INC
$50.49MN/A0.00%N/AN/AN/AN/A
IVA
INVENTIVA SA
$176.15MN/A0.00%N/AN/AN/AN/A
DDC
DDC ENTERPRISE LTD
N/AN/AN/AN/AN/AN/AN/A
CLRB
CELLECTAR BIOSCIENCES INC
$99.04MN/A0.00%N/AN/AN/AN/A
HOOK
HOOKIPA PHARMA INC
$75.99MN/A0.00%N/AN/AN/AN/A
SPRB
SPRUCE BIOSCIENCES INC
$34.28MN/A0.00%N/AN/AN/AN/A
PASG
PASSAGE BIO INC
$81.73MN/A0.00%N/AN/AN/AN/A
CARA
CARA THERAPEUTICS INC
$39.13MN/A0.00%N/AN/AN/AN/A
NTBL
NOTABLE LABS LTD
$11.27MN/A0.00%N/AN/AN/AN/A
AMLX
AMYLYX PHARMACEUTICALS INC
$119.35MN/A0.00%N/AN/AN/AN/A
SGMO
SANGAMO THERAPEUTICS INC
$116.41MN/A0.00%N/AN/AN/AN/A
CRBU
CARIBOU BIOSCIENCES INC
$319.72MN/A0.00%N/AN/AN/AN/A
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.